Affiliation:
1. Department of Microbiology, Toronto Hospital, Ontario, Canada.
Abstract
Fungal infections and antifungal resistance are increasingly recognized. Antifungal susceptibility testing remains unstandardized, and a particularly important problem is endpoint determination. In this paper we propose the yeast metabolic reduction of the tetrazolium salt 2,3-bis(2- methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetraz olium hydroxide (XTT) as a colorimetric endpoint which is quantitative and objective. Amphotericin B, fluorocytosine, and fluconazole dose-response curves were obtained, and a metabolic MIC could be determined by using precise criteria.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference21 articles.
1. Feasibility of drug screening with panels of human tumor cell lines using a microtiter tetrazolium assay;Alley M. C.;Cancer Res.,1988
2. Tetrazolium salts and formazans;Altman F. L.;Prog. Histochem. Cytochem.,1976
3. Potential of a soluble tetrazolium/formazan assay for the evaluation of filarial viability;Comley J. C.;Int. J. Parasitol.,1990
4. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests;Espinel-Ingroff A.;J. Clin. Microbiol.,1991
5. Comparison of tetrazolium colorimetric and 3H-uridine assays for in vitro chemosensitivity testing;Ford C. H. J.;Cancer Chemother. Pharmacol.,1989
Cited by
83 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献